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Heterogeneityamongcellsthatconstituteasolidtumorisimportantindeterminingdiseaseprogression.Ourpreviousworkestab-
lished that, within a population of metastatic colonic tumor cells, there are minor subpopulations of cells with stable diﬀerences in
theirintrinsicmitochondrialmembranepotential(ΔΨm),andthatthesediﬀerencesinΔΨmarelinkedtotumorigenicphenotype.
Here we expanded this work to investigate primary mammary, as well as colonic, tumor cell lines. We show that within a primary
mammary tumor cell population, and in both primary and metastatic colonic tumor cell populations, there are subpopulations
of cells with signiﬁcant stable variations in intrinsic ΔΨm. In each of these 3 tumor cell populations, cells with relatively higher
intrinsicΔΨmexhibitphenotypicpropertiesconsistentwithpromotionoftumorcellsurvivalandexpansion.However,additional
properties associated with invasive potential appear in cells with higher intrinsic ΔΨm only from the metastatic colonic tumor cell
line. Thus, it is likely that diﬀerences in the intrinsic ΔΨm among cells that constitute primary mammary tumor populations, as
well as primary and metastatic colonic tumor populations, are markers of an acquired tumor phenotype which, within the context
of the tumor, inﬂuence the probability that particular cells will contribute to disease progression.
1.Introduction
Cancerisahighlyheterogeneousdiseaseanddiversityamong
cells that make up solid tumors likely inﬂuences the proba-
bilityoftumorexpansionandprogression[1].Abnormalities
in mitochondrial (mt) structure and function [2–4]a n da
general elevation in the mitochondrial membrane potential
(ΔΨm) [5–9] have been linked to malignant transformation.
We previously reported that within the population of SW620
cells, a cell line established from a human metastatic colon
tumor [10], there are minor subpopulations of cells with
signiﬁcant stable diﬀerences in intrinsic ΔΨm and that these
diﬀerences in ΔΨm are linked to tumorigenic phenotype
[11].
To address the question of whether stable diﬀerences in
intrinsic ΔΨm exist among cells in other tumor cell pop-
ulations and, if so, whether these diﬀerences are similarly
linked to tumorigenic phenotypes, we generated single cell
subclones from SW480 cells, a cell line established from the
primary colon tumor of the same patient from which SW620
cells were established [10] and from MCF7 primary mam-
mary carcinoma cells [12].
Here we report that, consistent with our previous work,
there are signiﬁcant and stable diﬀerences in the intrinsic
ΔΨm among a minor fraction of cells within a population
of both SW480 and MCF7 cells and that these diﬀerences in
ΔΨm are again linked to tumorigenic phenotype, with eleva-
tionsintheintrinsicΔΨmassociatedwithdecreasedsensitiv-
ity to the chemoprotective agent butyrate and increased con-
stitutive, hypoxia-independent VEGF secretion. Moreover,
we demonstrate that unlike the diﬀerences in ΔΨm of clones
from SW620 cells, the intrinsic ΔΨmo fs u b c l o n e sd e r i v e d
from the SW480 primary colonic tumor cell population, or
from the MCF7 primary mammary tumor cell population,
d on o ti m p a c ti n v a s i v ep o t e n t i a l .2 International Journal of Cell Biology
Thus, our data establish signiﬁcant stable heterogeneity
in the intrinsic ΔΨm among subpopulations of cells of
both a primary and metastatic colon tumor and from a
primary mammary tumor and suggest that diﬀerences in
intrinsic ΔΨm are not random variations or passive indices
of heterogeneity, but rather markers of acquired behavior of
subpopulations cells which, within the context of the tumor,
are likely selected for, and contribute to, clinical progression
of the disease [13].
2.MaterialsandMethods
2.1. Quantitation of ΔΨm (Mitochondrial Membrane Poten-
tial). The ΔΨm was determined as previously described
by staining cells with the ΔΨm-dependent ﬂuorescent dye
JC-1 (5,5 ,6,6 -tetrachloro-1,1 ,3,3  tetraethylbenzimidazol
carbocyanineiodide; Molecular Probes, Eugene, OR) and
analyzing ﬂuorescence emission by ﬂow cytometry in detec-
tion channel 2 (FL-2) [14–17].
2.2. Quantitation of Viability in CoCl2 Simulated Hypoxia.
Cells grown to 80% conﬂuence were incubated for 24 hours
in medium alone or in medium containing 100mM CoCl2.
Cell viability was then determined by the MTT assay [18].
2.3. Quantitation of Response to Butyrate. Cells at approx-
imately 80% conﬂuence were treated with medium alone
or with medium containing 5mM sodium butyrate (NaB)
(Sigma,St.Louis,MO).Seventy-twohourslater,cellviability
was determined by the MTT assay [18].
2.4. Quantitation of Secretion of Matrilysin (MMP7) and
Vascular Endothelial Growth Factor (VEGF). Cells were
seeded into 96-well plates and grown to approximately
80% conﬂuence. Conditioned tissue culture medium was
then harvested, and MMP7 and VEGF165 protein levels
were quantiﬁed by ELISA (R&D Systems, Inc., Minneapolis,
MN) according to the manufacturer’s protocol. Constitutive
MMP7 and VEGF165 secretion levels were normalized by
determining cells per well by the MTT assay and expressed
relative to the population of cells.
2.5. Quantitation of Fascin Protein by Immunoblotting. Cells
grown to approximately 80% conﬂuence were washed twice
in ice cold PBS and lysed in buﬀer containing 0.5% NP-40,
1% Triton X-100, 0.2mM sodium orthovanadate, 0.2mM
PMSF, 1mM EDTA (pH 8), 1mM EGTA (pH 8), 150mM
NaCl, and 10mM Tris pH 7.4. Lysates were cleared by
centrifugation and protein concentration determined (Bio-
Rad, Hercules, CA). Thirty μg of cell lysates were size-
fractionated on 4–20% acrylamide SDS-PAGE gels (Bio-
Rad, Hercules, CA) and blotted onto PVDF membranes
(Amersham, Arlington Heights, IL). Replicate blots were
probed with antibodies directed against fascin (Millipore,
Billerica, MA) or actin (EMD Biosciences, Gibbstown, NJ),
followed by incubation with appropriate secondary antibod-
ies.Reactionsweredetectedbyenhancedchemiluminescence
and quantiﬁed by densitometry using Kodak IS4000R and
Kodak Molecular Imaging Software.
2.6. Quantitation of Cell Invasion. Cells were seeded into
chambers consisting of a reconstituted basement mem-
brane supported by an underlying polycarbonate membrane
(Millipore, Billerica, MA). Invasion through the basement
membrane was determined by the staining and subsequent
quantiﬁcation by optical density at 560nM, of cells adhering
to the polycarbonate membrane.
2.7. Statistical Analyses. Data from at least 3 independent
determinations of the intrinsic ΔΨmw e r ea n a l y z e db yB o n -
ferroni’s Multiple Comparison Test. Mean data from other
determinations were evaluated as a function of the relative
intrinsic ΔΨm using linear regression analyses.
3. Results
3.1.SubpopulationsofCellswithinPrimaryColonicandMam-
mary Carcinoma Cell Populations Exhibit Stable Diﬀerences in
Intrinsic ΔΨm. JC-1 is a lipophilic, cationic ﬂuorescent dye
that exhibits ΔΨm-dependent uptake, accumulation, and
aggregate formation in the mitochondria [19]. The emission
intensity of these aggregates at 590nm, analyzed by ﬂow
cytometry in ﬂuorescence detection channel 2 (FL-2), is a
sensitive index of the cell’s ΔΨm[ 15, 17]. In our previous
work, we demonstrated that the distribution of JC-1 staining
of metastatic colonic tumor SW620 cells reﬂected the pres-
ence of subpopulation of cells with stable diﬀerences in in-
trinsic ΔΨm[ 11].
Here we investigated whether the distribution of JC-1
stained SW480 cells (Figure 1(a)), a cell line established
from the primary colon tumor of the same patient from
which metastatic SW620 cells were established [10], and
from MCF7 cells (Figure 2(a)), a primary mammary tumor
[12],alsoreﬂectedstablediﬀerencesinintrinsicΔΨmamong
cells that constitute the population.
Similar toour previous work[11],suspensions of SW480
or MCF7 cells were diluted such that there was a high proba-
bility that a single cell was placed into standard tissue culture
wells.From272wellsseededwithSW480cells,149subclones
were generated and expanded. Assuming that a single cell
was placed into each well, these data suggest that 54.8% of
primary colonic tumor SW480 cells were capable of clonal
growth and expansion, comparable to our previous work in
which 53.8% of metastatic colonic tumor SW620 cells were
capable of generating subcloned cell lines [11].
The SW480 parental population and each of 149 derived
subclonedcelllineswerethenstainedwithJC-1andanalyzed
by ﬂow cytometry. The intrinsic ΔΨmo fe a c ho fs u b -
cloned lines was expressed relative to that of the unselected
population of cells and plotted as a frequency distribution
(Figure 1(b)). The relative ΔΨm of the 149-subcloned cell
lines derived from SW480 cells ranged from approximately
0.17-fold below, to 2.30-fold above, that of the mean of the
population.International Journal of Cell Biology 3
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Figure 1: Subpopulations of cells within a primary colonic carcinoma cell population exhibit stable diﬀerences in intrinsic ΔΨm. (a) The
SW480celllinestainedwithJC-1andanalyzedbyﬂowcytometryinFL-2.(b)TheparentalpopulationofSW480and149subclonedcelllines
were stained with JC-1, analyzed by ﬂow cytometry, the intrinsic ΔΨm each subcloned line was expressed relative to that of the unselected
population of SW480 cells and plotted as a frequency distribution. (c) 13 subcloned cell lines derived from SW480 cells were selected from
further study: the intrinsic ΔΨm of subclones “ΔΨmL” range from 0.17 and 0.50 fold lower; subclones “ΔΨmE” equivalent; and subclones
“ΔΨmH” from 1.60 to 2.30 fold higher than that of the population of SW480 cells (also see Figure 1(b)). Mean and SEM of multiple ΔΨm
determinations made over approximately 1 year. The intrinsic ΔΨmo fa l lo ft h eΔΨmL subclones are statistically diﬀerent from all of the
ΔΨmH subclones (Bonferroni’s Multiple Comparison Test; P ≤ 0.05).
For subsequent investigations, we focused on 13 of the
SW480 subcloned lines falling into 3 groups. As shown in
Figures 1(b) and 1(c), the mitochondrial membrane poten-
tialsofsubclonedlinesinthegroupdesignatedΔΨmL arebe-
tween 0.17- and 0.50-fold lower than that of the population
of SW480 cells; the ΔΨm of the subcloned lines in the ΔΨmE
subgroup are comparable to that of the population of cells;
and the ΔΨm of the subclones in the ΔΨmH subgroup are
1.60- to 2.30-fold higher than that of the population of cells.
Similartoourpreviousworkinvestigating intrinsic ΔΨm
of SW620-derived clones [11, 20], the intrinsic ΔΨmo f
subcloned cell lines derived from SW480 cell are highly
stable, demonstrated by the consistency among multiple
determinations made over a period of approximately 1 year
and hence standard errors that are consistently <10% of
the means (Figure 1(c)). Moreover, evaluation of these data
by Bonferroni’s Multiple Comparison Test shows that the
intrinsic ΔΨm of all of the ΔΨmL subclones are statistically
diﬀerent from all of the ΔΨmH subclones (P ≤ 0.05).
Similarly, 83 subclones derived from the MCF7 popu-
lation were expanded, the intrinsic ΔΨmo fe a c hw a sd e -
termined by JC-1, expressed relative to the population and
plottedasafrequencydistribution(Figure 2(b)).Therelative
ΔΨm of these subcloned cell lines ranged from approxi-
mately 0.43-fold below to 1.80-fold above that of the mean
of the population.
We focused on 11 of the MCF7 subcloned lines; 2 with
intrinsic ΔΨm at least 15% lower, 2 with ΔΨmc o m p a r a b l e ,
and 7 with intrinsic ΔΨm at least 15% higher than that
of the population of MCF7 cells (Figure 2(c)). Bonferroni’s
Multiple Comparison Test of these data shows that the lower
intrinsic ΔΨm are statistically diﬀerent from the higher
intrinsic ΔΨm( P ≤ 0.05).
Thus, these data extend the ﬁnding of minor subpopu-
lations of cells with signiﬁcant stable diﬀerences in intrinsic
ΔΨm from SW620 metastatic colon tumor cells [11] to the
primarycolontumorcellsofthesamepatientandtoprimary
MCF7 mammary carcinoma cells.
3.2. Diﬀerences in the Intrinsic ΔΨm of Subcloned Cell Lines
Derived from Primary Colon and Mammary Tumors Are
Linked to Sensitivity to the Chemoprotective Agent Sodium
Butyrate (NaB). The unbranched short chain fatty acid
butyrate is a natural constituent of the colonic contents,
present at high concentrations due to its generation during4 International Journal of Cell Biology
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Figure 2: Subpopulations of cells within primary mammary carcinoma cell population exhibit stable diﬀerences in intrinsic ΔΨm. (a) The
MCF7 cell line stained with jc-1 and analyzed by ﬂow cytometry in FL-2. (b) The parental population of MCF7 and 83 subcloned cell lines
were stained with JC-1, analyzed by ﬂow cytometry, the Intrinsic ΔΨm each subcloned line was expressed relative to that of the unselected
population of MCF7 cells and plotted as a frequency distribution. (c) 11 subcloned cell lines derived from SW480 cells were selected from
further study. Mean and SEM of triplicate ΔΨm determinations made over approximately 3 months. Lower intrinsic ΔΨm are statistically
diﬀerent from higher intrinsic ΔΨm (Bonferroni’s Multiple Comparison Test; P ≤ 0.05).
ﬁber fermentation in the large intestine [21, 22]. Rapidly
taken up by cells, butyrate enters the mitochondria where it
undergoesβ-oxidation[23].Inadditiontofunctioningasthe
primary energy source for colonic epithelial cells [24], NaB
mediates maturation and apoptotic pathways in vitro and in
vivo [25–27] thereby likely suppressing development and/or
progression of colon cancer [28–31].
Butyrate also has potent eﬀects on a variety of other cell
types, including normal and malignant mammary epithelial
cells [32, 33]. However, due to its rapid in vivo metabolism,
it is diﬃcult to achieve and maintain eﬀective serum levels
even when butyrate salts are administered by continuous
i.v. [34, 35]. We have reported that tributyrin, a triglyceride
analogue of butyric acid that generates and maintains
higher serum butyrate levels than NaB [36, 37], initiates
growth arrest and apoptosis of MCF7 cells associated with
mitochondrial activity [16] and foundthat dietary tributyrin
eﬀectively decreases the incidence, and increases the latency,
of carcinogen induced mammary tumors in BALB/c mice
(Heerdt et al., unpublished observation).
We have shown that the ΔΨmp l a y sac r i t i c a lr o l ei nN a B
initiated cell cycle arrest and apoptotic pathways in SW260
cells [14, 17] and that diﬀerences in the intrinsic ΔΨm
signiﬁcantly impact cellular sensitivity to NaB [11, 14, 20].
Therefore, to investigate the relationship between the intrin-
sic ΔΨm of primary tumor SW480 and MCF7 derived
subclones and NaB sensitivity, the population of SW480-
and the 13-derived subcloned cell lines (Figure 1(c)), and the
MCF7 population and 11 derived subclones (Figure 2(c)),
were exposed to 5mM NaB, a physiologically relevant
concentration [21, 38], for 72 hours. Viability relative to
untreatedcellswasthendeterminedandplottedasafunction
of relative ΔΨm. As shown in Figure 3,d i ﬀerences in the
cellularsensitivitytoNaBareafunctionoftheintrinsicΔΨm
ofsubclonedcelllinesderivedfromSW480cells(P<0.0001)
or from MCF7 cells (P = 0.0005) with elevated ΔΨm linked
to decreased sensitivity, consistent with our previous work
[11, 14, 20].
3.3. Diﬀerences in the Intrinsic ΔΨm of Subcloned Cell Lines
Derived from Primary Colonic and Mammary Tumors Are
Linked to Phenotypes Associated with Solid Tumor Expansion.
Rapid growth and expansion of solid tumors produces
regions where the demand for oxygen exceeds that which
can be obtained by diﬀusion from existing blood vessels,
resulting in areas of hypoxia. Therefore, to expand beyondInternational Journal of Cell Biology 5
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Figure 3: Diﬀerences in the Intrinsic ΔΨm of subcloned cell lines
derived from primary colon and mammary tumors and from a
metastaticcolontumorarelinkedtosensitivitytothechemoprotec-
tive agent sodium butyrate (NaB). The SW480 and MCF7 cell lines,
and subclones derived from each of the cell lines, were exposed to
5mm NaB for 72 hours. Viability was determined by MTT assay,
expressed relative to untreated cells, and plotted as a function of
relative ΔΨm.
approximately 1-2mm in diameter, tumors need to acquire
an independent blood supply [39–41]. Vascular endothelial
growth factor (VEGF) promotes new endothelial and lym-
phatic vessel formation in tumors and has been linked to
poor prognosis [42]. Our previous work has established a
signiﬁcant impact of the intrinsic ΔΨmo fc l o n e sd e r i v e d
from SW620 cells and constitutive, hypoxia-independent
secretion of VEGF [11, 20]. Here we show that, similarly, the
intrinsic ΔΨm of SW480 and MCF7 subclones is linked to
VEGF secretion (P = 0.0002 and P = 0.015, resp.) with
elevated ΔΨm generally associated with increased levels of
secretion (Figure 4).
3.4. Diﬀerences in the Intrinsic ΔΨm of Subcloned Cell Lines
Derived from a Metastatic Colonic Tumor, but Not from the
Paired Primary Colonic Tumor or from a Primary Mammary
Tumor, Are Linked to Phenotypic Markers Associated with
Invasion. For successful invasion and metastasis, tumor
cells must degrade and penetrate the extracellular matrix.
Key enzymes in these processes include matrix metallo-
proteinases (MMPs). Whereas most MMPs are produced
by stromal cells, MMP7 (matrilysin) is synthesized by
tumor cells and its elevated expression, particularly at a
tumor’s invasive edge, is characteristic of metastatic cancer
cells [43–45]. We have previously shown that metastatic
SW620 cells constitutively secrete MMP7 and that secretion
levels are a function of the intrinsic ΔΨm, with elevated
intrinsic ΔΨm associated with higher MMP7 secretion
[11].
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Figure 4: Diﬀerences in the intrinsic ΔΨm of subcloned cell lines
derived from primary colonic and mammary tumors are linked
to phenotypes associated with solid tumor expansion. VEGF was
quantiﬁed by ELISA in condition medium harvest from SW480 and
MCF7 cell lines, and subclones derived from each of the cell lines,
and normalized for cells/well by the MTT assay. VEGF secretion
levels are plotted as a function of relative ΔΨm.
To investigate whether there is a similar relationship
betweenconstitutiveMMP7secretionandtheintrinsic ΔΨm
of SW480- or MCF7-derived subclones, MMP7 protein
levels were quantiﬁed in harvested conditioned medium and
plotted as a function of the ΔΨm of each cell line. Consistent
with previous reports, we found that mean constitutive
MMP7 secretion in the parental population of SW480 cells is
approximately 50% lower than that of the metastatic SW620
cell population (Figure 5(a); P<0.0001) [46, 47], and that
MMP7 secretion is not detected in the MCF7 population
[48]. Furthermore, in contrast to stable diﬀerence in the
ΔΨm of SW620-derived subclones [11, 20], the intrinsic
ΔΨm of neither SW480- nor MCF7-derived subclones
is signiﬁcantly associated with levels of MMP7 secretion
(Figure 5(b), P = 0.303 and not shown, resp.).
Because acquisition of an invasive phenotype in colonic
carcinoma is linked to upregulation of the actin binding pro-
tein fascin [49, 50], we next determined fascin protein levels
in the parental cell populations and in subcloned cell lines
by immunoblotting (Figure 5(c)). Consistent with the role of
fascin in invasion, there is a signiﬁcant association between
fascin and the intrinsic ΔΨm of subcloned cell lines derived
from the SW620 metastatic colonic carcinoma cell line (P =
0.007), with elevated ΔΨm linked to higher levels of fascin
protein, similar to the association between elevated ΔΨmo f
SW620 subclones and MMP7 secretion [11, 20]. In contrast,
however, fascin levels are not correlated with the intrinsic
ΔΨmo fs u b c l o n e sd e r i v e df r o mp r i m a r yc o l o nt u m o rc e l l
line SW480 (P = 0.539) nor in the subclones derived from
MCF7 mammary carcinoma cells (P = 0.415; not shown).6 International Journal of Cell Biology
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Figure 5: Diﬀerences in the intrinsic ΔΨm of subcloned cell lines derived from a metastatic colonic tumor, but not from the paired primary
colon tumor, are linked to phenotypic markers associated with invasion. (a) and (b) MMP7 secretion levels were quantiﬁed by ELISA in
condition medium harvest from SW480 and SW620 Cells (a) and from 13 subcloned cell lines derived from SW480 cells (b) and normalized
for cells/well by the MTT assay. Secretion levels in parental SW480 and derived subclones are plotted as a function of relative ΔΨm( b ) .( c )
Fascin levels were determined in the SW480 and SW620 cell lines, and subclones derived from each of the cell lines, by immunoblotting
normalized to actin. Reactions were quantiﬁed by densitometry and plotted as a function of relative ΔΨm.
3.5. Unlike Subclones Derived from Metastatic SW620 Colonic
Tumor Cells, DiﬀerencesintheIntrinsicΔΨmofSubclonedCell
Lines Derived from Paired Primary SW480 Colon Tumor Cells
Are Not Linked to Diﬀerences in Invasion. Finally, because
we have shown that the intrinsic ΔΨmo fs u b c l o n e dc e l l
lines derived from metastatic SW620 cells correlates with
their ability to invade an artiﬁcial basement membrane in
vitro [11, 20], we investigated the inﬂuence of diﬀerences in
the intrinsic ΔΨm on invasive capacity of subclones derived
from SW480 cells, established from the primary tumor of
the same patient. Consistent with previous reports [46, 47],
SW480 cells exhibited approximately 77% lower invasion
through reconstituted basement membrane when compared
to SW620 cells (Figure 6(a); P<0.0001). Furthermore,International Journal of Cell Biology 7
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Figure 6:DiﬀerencesintheintrinsicΔΨmofsubclonedcelllinesderivedfromprimarycolontumorarenotlinkedtodiﬀerencesininvasion.
SW480 and SW620 cells (a) and subcloned cell lines derived from SW480 cells (b) were seeded into chambers containing a reconstituted
basement membrane overlying a polycarbonate membrane. Invasion was quantiﬁed by staining cells adhering to the polycarbonate and
determining optical density (560nM) normalized to cells/chamber. Invasion of parental SW480 and derived subclones are plotted as a
function of relative ΔΨm( b ) .
as suggested by the absence of an association between the
intrinsic ΔΨm and MMP7 secretion or fascin expression
levels (Figures 5(b) and 5(c),r e s p . ) ,d i ﬀerences in the
intrinsic ΔΨm of subcloned cell lines derived from SW480
primary colonic tumor cells are not associated with coinci-
dent diﬀerences ability to invade a reconstituted basement
membrane (Figure 6(b); P = 0.806).
4. Discussion
Heterogeneity is a fundamental property of cellular systems,
including solid tumors [1]. Diversity among tumor cells
likely provides reservoirs of cells that can tolerate and/or
rapidly respond to changing environmental conditions, and/
or escape preventative or therapeutic intervention, thereby
increasing the probability of tumor expansion and progres-
sion in spite of shifting microenvironments. Consistent with
this, the data presented here, combined with our previous
work [11], establish that there exist subpopulations of cells
with stable diﬀerences in the intrinsic ΔΨmi np a i r e dp r i -
mary and metastatic colonic carcinoma cell lines (SW480
and SW620, resp.) as well as in a primary mammary carcino-
ma cell line (MCF7) and demonstrate the impact of intrinsic
ΔΨmo nt u m o rc e l lp h e n o t y p e .
We show that in subclones derived from each of these cell
lines, diﬀerences in intrinsic ΔΨm are linked to sensitivity to
the chemoprotective agent NaB, with increased ΔΨm linked
to decreased NaB-mediated cytotoxicity. Because malignant
transformation is associated with a general elevation in the
ΔΨm[ 5–9], these data suggest that the normally chemo-
protective eﬀects of NaB may be particularly diminished in
subpopulations of cells with relatively higher intrinsic ΔΨm,
thereby increasing the probability of their contribution to
tumor progression. Moreover, we have reported previously
that, unlike NaB, derivatives that are ineﬃciently metab-
olized by mitochondrial β-oxidation, including branched
isobutyric acid and a ﬂuorine-substituted analogue, hep-
taﬂuorobutyricacid[51],areineﬀectiveininducingthesame
responses that are mediated by NaB in colonic carcinoma
cells in vitro [25, 52, 53]. Therefore, it is likely that the
metabolism of NaB plays a critical role is its eﬀects on
tumor cells in vitro and that the diﬀerences in NaB sensitivity
associated with intrinsic ΔΨm of subcloned cell lines derived
from metastatic and primary colon tumors, and from a
primary mammary tumor, may be related to alterations in
mitochondrial metabolic activity.
We also show that diﬀerences in intrinsic ΔΨmi ns u b -
clones derived from primary mammary carcinoma cells, as
well as primary and metastatic colon carcinoma cells, are
linked to phenotypes consistent with expansion of solid
tumors with elevated intrinsic ΔΨm associated with in-
creased levels of constitutive, hypoxia-independent VEGF
secretion. These results suggest the presence of pseudohy-
poxia, the activation of hypoxia-like pathway(s) under nor-
moxic conditions, in cells with elevated intrinsic ΔΨm. Pseu-
dohypoxia is achieved by either defective TCA cycle-
mediated impaired degradation of HIF1α or by accelerated
mTOR-mediated translation of HIF1α [54–57]. Activation
of the mTOR pathway is sensitive to mitochondrial function
and the ΔΨm[ 58, 59] and our data suggest increased consti-
tutive mTOR activation in subcloned cell lines with elevated
intrinsic ΔΨm (Heerdt and Houston, in preparation).
Whereas stable diﬀerences in the intrinsic ΔΨmo fs u b -
clones derived from the metastatic colonic carcinoma cell
line are linked to diﬀerences in invasive capacity [11], dif-
ferences in intrinsic ΔΨma r enot linked to invasive potential
in subclones derived from the paired primary colonic car-
cinoma cell line or from the primary mammary tumor cell8 International Journal of Cell Biology
line investigated here. Therefore, while subpopulations of
cells with higher intrinsic ΔΨmf r o mb o t hp r i m a r ya n d
metastatic colonic tumors, and from a primary mammary
tumor, acquire properties likely reﬂecting endogenous cellu-
lar resilience, demonstrated by decreased sensitivity to NaB-
induced cytotoxicity, or are primed to rapidly adjust to alter-
ations in microenvironment, demonstrated by constitutive
hypoxia-independentVEGFsecretion,otherproperties,such
as enhanced invasive potential, appear only in subpopu-
lations of cells with elevated ΔΨm that are components
of a metastatic tumor. Thus, the relationship between the
intrinsic ΔΨm and invasive potential may be secondary to
its relationship with phenotypes associated with local solid
tumor expansion.
Although the mechanisms involved in generating and
maintaining diﬀerences in ΔΨm are unclear, they may reﬂect
alterations in the composition of mitochondrial membranes
[60–65](MariadasonandHeerdt,unpublishedobservation),
modulations in expression of mitochondrial targeted nuclear
genes [66], or enrichment in a particular mitochondrial
population. As many as 90% of colorectal tumors have at
least one somatic point mutation in mitochondrial DNA
(mtDNA) [67–70], the majority of which are heteroplasmic,
in that both wild-type and mutant mitochondrial genomes
are present in the tumor [67–70]. Because the mt genome
encodessubunitcomponentsoftheelectrontransportchain,
which is responsible for generating the ΔΨm, mtDNA
mutations, can impact the ΔΨm[ 4, 71–74]. Moreover, there
is at least one common heteroplasmic mtDNA mutation in
subcloned cell lines with elevated intrinsic ΔΨmd e r i v e d
from either the SW620 or SW480 cell lines, which was
not identiﬁed in cells with decreased ΔΨm (Heerdt et al.,
unpublished observation). There may also be additional
heteroplasmic mtDNA populations in SW620 metastatic
compared to SW480 primary colonic carcinoma cell lines
[75]. Therefore, accumulation and/or enrichment of partic-
ular mtDNA mutations may reﬂect and/or generate stable
diﬀerences in intrinsic ΔΨm and accompanying tumorigenic
phenotype, and that added mtDNA alterations may be
further linked to increasing clinical stage.
Interestingly, in patients with stage III colon cancers,
resistance to ﬂuorouracil-based chemotherapy has been
linked to speciﬁc somatic mtDNA mutations [76], and we
have found a signiﬁcant correlation between the ΔΨmo f
colonic carcinoma cell lines and sensitivity to 5-ﬂuorouracil
(Heerdt et al., unpublished observation). Thus, alterations in
intrinsicΔΨm,perhapsassociatedwithaccumulationand/or
enrichment of particular mtDNA populations, impact cellu-
lar response to chemoprotective, as well as to chemothera-
peutic, agents.
The steep electrochemical proton gradient across the
mitochondrial inner membrane is mainly accounted for
by its matrix-side-negative electrical component, the ΔΨm.
Based on Nernst’s law, cations capable of permeating biolog-
ical membranes can accumulate in the mitochondrial matrix
at a 10-fold higher level with each 60mV of transmembrane
voltage[77].Therefore,althoughthemechanismsgenerating
and maintaining the stable relative diﬀerences in ΔΨm
remain to be established, modest elevations in the ΔΨmc a n
be exploited by mitochondriotropic agents to preferentially
target attached cytotoxic agents into the mitochondrial
matrix [6, 9, 76, 78, 79], particularly of cells within both
primary and metastatic tumor populations that our data
showasthemostlikelytocontributetotumorexpansionand
progression.
In summary, our data suggest that stable diﬀerences in
intrinsic ΔΨm among cells that comprise colon and mam-
mary tumors reﬂect cellular heterogeneity and identify cells
that are important in tumor progression and potential pre-
dictors of response to, and targets of, chemoprotection and
chemotherapy.
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